NEWPORT NEWS, Va., Sept. 10, 2018 /PRNewswire/ -- Solsys Medical, LLC ("Solsys") (formerly known and doing business as SolubleSystems, LLC) ("Solsys Medical"), which markets TheraSkin®, a cellular and tissue-based product for regenerative wound healing, announced today that it has partnered with Healogics, the nations largest provider of advanced chronic wound care services,
"We are very excited to be working with Healogics and have TheraSkin included in its iSupply initiative," stated Allan Staley, CEO of Solsys Medical. "The iSupply program enables Healogics' hospital partners improved access to TheraSkin in order to improve wound healing outcomes at a lower cost."
"We believe that high quality products at better prices translates into better care for people living with chronic wounds," said David Bassin, Chief Executive Officer at Healogics. "This first-of-its-kind program will be available at no additional charge to our partners, and will make a serious impact, not only on their bottom line, but on the consistency of supplies used during patient care. We expect this program to make an important impact on the cost of patient care. There is no other program like it today, and we are excited that Solsys Medical is part of iSupply."
About Solsys Medical, LLC: Solsys Medical, LLC™ (formerly known and doing business as Soluble Systems, LLC) markets TheraSkin, a regenerative medical product, designed by nature and made for healing, to help healthcare professionals treat difficult to heal chronic wounds.
About TheraSkin: TheraSkin is a clinically proven, minimally manipulated, cryopreserved human skin allograft containing the relevant human biological components needed to help repair and heal difficult to heal chronic wounds.
For more information on TheraSkin and Solsys Medical, LLC, visit www.solsysmedical.com
View original content:http://www.prnewswire.com/news-releases/solsys-medicals-theraskin-regenerative-wound-healing-product-chosen-to-be-a-part-of-healogics-new-isupplysm-program-300708914.html
SOURCE Solsys Medical, LLC
Subscribe to our Free Newsletters!
DOOR syndrome is a rare genetic disorder marked by deafness, short or absent fingernails, abnormal ...
Are you gluten intolerant? Stay away from gluten allergy and celiac disease by shifting to ...
Moxetumomab pasudotox-tdfk is used to treat hairy cell leukemia (a form of chronic lymphocytic ...View All